These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18598349)

  • 21. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones.
    Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JWT; Tice JA; Ziv E; Kerlikowske K; Cummings SR
    Breast Cancer Res Treat; 2017 Nov; 166(2):603-612. PubMed ID: 28791495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
    Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
    J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for breast cancer according to estrogen and progesterone receptor status.
    Colditz GA; Rosner BA; Chen WY; Holmes MD; Hankinson SE
    J Natl Cancer Inst; 2004 Feb; 96(3):218-28. PubMed ID: 14759989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion.
    Tamimi RM; Rosner B; Colditz GA
    Cancer; 2010 Nov; 116(21):4944-53. PubMed ID: 20645399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of Rosner-Colditz breast cancer incidence model using an independent data set, the California Teachers Study.
    Rosner BA; Colditz GA; Hankinson SE; Sullivan-Halley J; Lacey JV; Bernstein L
    Breast Cancer Res Treat; 2013 Nov; 142(1):187-202. PubMed ID: 24158759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.
    Key TJ; Appleby PN; Reeves GK; Roddam A; Dorgan JF; Longcope C; Stanczyk FZ; Stephenson HE; Falk RT; Miller R; Schatzkin A; Allen DS; Fentiman IS; Key TJ; Wang DY; Dowsett M; Thomas HV; Hankinson SE; Toniolo P; Akhmedkhanov A; Koenig K; Shore RE; Zeleniuch-Jacquotte A; Berrino F; Muti P; Micheli A; Krogh V; Sieri S; Pala V; Venturelli E; Secreto G; Barrett-Connor E; Laughlin GA; Kabuto M; Akiba S; Stevens RG; Neriishi K; Land CE; Cauley JA; Kuller LH; Cummings SR; Helzlsouer KJ; Alberg AJ; Bush TL; Comstock GW; Gordon GB; Miller SR; Longcope C;
    J Natl Cancer Inst; 2003 Aug; 95(16):1218-26. PubMed ID: 12928347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous estrogen and postmenopausal breast cancer: a quantitative review.
    Thomas HV; Reeves GK; Key TJ
    Cancer Causes Control; 1997 Nov; 8(6):922-8. PubMed ID: 9427435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States).
    Hankinson SE; Colditz GA; Hunter DJ; Manson JE; Willett WC; Stampfer MJ; Longcope C; Speizer FE
    Cancer Causes Control; 1995 May; 6(3):217-24. PubMed ID: 7612801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort.
    Lu DL; Le Cornet C; Sookthai D; Johnson TS; Kaaks R; Fortner RT
    J Natl Cancer Inst; 2019 Apr; 111(4):365-371. PubMed ID: 30016454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women.
    Baglietto L; Severi G; English DR; Krishnan K; Hopper JL; McLean C; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):492-502. PubMed ID: 20086116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.
    Zeleniuch-Jacquotte A; Bruning PF; Bonfrer JM; Koenig KL; Shore RE; Kim MY; Pasternack BS; Toniolo P
    Am J Epidemiol; 1997 Jun; 145(11):1030-8. PubMed ID: 9169912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study.
    Wellejus A; Olsen A; Tjonneland A; Thomsen BL; Overvad K; Loft S
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2137-42. PubMed ID: 16172222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses' Health Study and Nurses' Health Study II.
    Hirko KA; Fortner RT; Hankinson SE; Wu T; Eliassen AH
    Breast Cancer Res Treat; 2016 Jul; 158(1):149-155. PubMed ID: 27294610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum estradiol level and risk of breast cancer during treatment with raloxifene.
    Cummings SR; Duong T; Kenyon E; Cauley JA; Whitehead M; Krueger KA;
    JAMA; 2002 Jan; 287(2):216-20. PubMed ID: 11779264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between menopausal status and obesity in affecting breast cancer risk.
    Rose DP; Vona-Davis L
    Maturitas; 2010 May; 66(1):33-8. PubMed ID: 20181446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of obesity and physical activity with serum and intratumoral sex steroid hormone levels among postmenopausal women with breast cancer: analysis of paired serum and tumor tissue samples.
    Kakugawa Y; Tada H; Kawai M; Suzuki T; Nishino Y; Kanemura S; Ishida T; Ohuchi N; Minami Y
    Breast Cancer Res Treat; 2017 Feb; 162(1):115-125. PubMed ID: 28044214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
    Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
    Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Estrogen-Related Dietary Pattern and Postmenopausal Breast Cancer Risk in a Cohort of Women with a Family History of Breast Cancer.
    Guinter MA; Sandler DP; McLain AC; Merchant AT; Steck SE
    Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1223-1226. PubMed ID: 30232064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.